Recruiting
Phase 2

Observational Study

Sponsor:

Brigham and Women's Hospital

Code:

NCT06366724

Conditions

ME/CFS

Long COVID

PASC

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Pyridostigmine

Low-Dose Naltrexone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-16. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2025-10-22.